Telomir Pharmaceuticals, Inc. (TELO)

NASDAQ: TELO · Real-Time Price · USD

1.270

-0.040 (-3.05%)

Feb 27, 2026, 4:00 PM EST - Market closed

Telomir Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	44	123	-	-	-
Enterprise Value	36	122	-	-	-
Last Close Price	1.27	4.12	-	-	-
PB Ratio	6.16	190.63	-	-	-
P/TBV Ratio	6.26	190.63	-	-	-
Debt / Equity Ratio	0.01	0.14	0.18	-0.62	-0.86
Net Debt / Equity Ratio	-1.04	-1.82	0.18	-0.62	-0.86
Quick Ratio	17.34	1.86	0.00	0.00	-
Current Ratio	17.51	1.94	0.33	0.05	-
Return on Equity (ROE)	-303.19%	-810.18%	-1045.36%	-	-
Return on Assets (ROA)	-167.42%	-250.96%	-102.18%	-	-
Return on Capital Employed (ROCE)	-162.00%	-1903.80%	-114.70%	91.10%	100.00%
Earnings Yield	-25.77%	-13.49%	-	-	-
Buyback Yield / Dilution	-6.22%	-8.18%	-1.77%	-	-

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q